Tissue engineering technique does not cause tumor growth

February 28, 2006

New Haven, Conn.--A gene therapy approach used in creating new arteries for older patients does not appear to cause cancer, according to a pilot study by Yale School of Medicine researchers reported in the Proceedings of the National Academy of Sciences.

Although the study was conducted on only eight patients, the results are promising for using the telomerase enzyme to extend the life of cells in older patients, said the senior author, Laura Niklason, associate professor in the Departments of Anesthesiology and Biomedical Engineering.

"This result is an encouraging step along the road to new tissues for patients to replace those that have failed or have been destroyed due to trauma or disease," she said.

Tissue engineers attempt to replace or repair bodily organs using cells or tissues grown in the laboratory. However, many strategies that work with animal cells do not work with cells taken from human patients. One problem for growing new arteries from cells biopsied from older patients with vascular disease is that the cells grow only for a short time in the laboratory before they stop dividing and become too "old" to form a tissue.

In order to get around this problem, Niklason, in research published last year, used a gene therapy approach to deliver telomerase, an enzyme that has been shown to lengthen the lifespan over which cells could divide. When her lab added the telomerase gene to vascular cells from older people, she found that she could grow blood vessels for every single patient that she studied.

The problem is that telomerase is also involved in the ability of most tumor cells to grow indefinitely. While there is essentially no evidence that telomerase by itself can create cancer, Niklason felt compelled to study the safety of the blood vessel cells into which she had inserted telomerase. This current study in PNAS studied that question.

"The cells were put through multiple tests," she said. "In no cases did the team find that telomerase-containing cells were capable of forming tumors, either in the lab or in animals. In addition, the team found that telomerase-containing cells actually had chromosomal makeups that were more normal than control cells, in other words, adding telomerase appeared to protect chromosomal integrity, to some degree."

Niklason said they will study cells from many more patients before they can deem the strategy truly safe.
PNAS 103: 2500-2505 (February 21, 2006)

Yale University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.